Macquarie Group LTD Collegium Pharmaceutical, Inc Transaction History

Macquarie Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $4,514 - $5,869	-292 Closed	0 $5,000
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $2,675 - $3,627	-139 Reduced 32.25%	292 $7,000
Q2 2020 Aug 11, 2020	BUY	$15.49 - $23.51 $6,676 - $10,132	431 New	431 $8,000
Q3 2019 Nov 14, 2019	SELL	$10.16 - $13.28 $5.05 Million - $6.6 Million	-497,011 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $20.3 Million - $31.8 Million	-1,914,707 Reduced 79.39%	497,011 $6.54 Million
Q1 2019 May 15, 2019	SELL	$13.58 - $18.72 $4.72 Million - $6.5 Million	-347,289 Reduced 12.59%	2,411,718 $36.5 Million
Q4 2018 Feb 15, 2019	BUY	$14.78 - $19.68 $3.28 Million - $4.36 Million	221,779 Added 8.74%	2,759,007 $47.4 Million
Q3 2018 Nov 15, 2018	SELL	$14.16 - $24.3 $723,972 - $1.24 Million	-51,128 Reduced 1.98%	2,537,228 $37.4 Million
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $5.09 Million - $6.61 Million	233,598 Added 9.92%	2,588,356 $61.7 Million
Q1 2018 May 11, 2018	BUY	$18.15 - $29.21 $13.4 Million - $21.6 Million	738,641 Added 45.7%	2,354,758 $60.2 Million
Q4 2017 Feb 15, 2018	BUY	$9.3 - $19.14 $2.66 Million - $5.48 Million	286,138 Added 21.51%	1,616,117 $29.8 Million
Q3 2017 Nov 08, 2017	BUY	$9.15 - $11.97 $12.2 Million - $15.9 Million	1,329,979	1,329,979 $14 Million

249

36.2M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.